MGAT5 and metabolic dysfunction-associated steatotic liver disease: We observed a significantly upregulated expression of MGAT5 in HBV- and NAFLD-associated fibrosis in patients with advanced disease (advanced fibrosis) compared to those at the initial stage of the disease or without fibrosis (Figure 5F).